[1] TU Yadan CHEN Yong FANG Bangjiang, REN Yi LIU Li,.TCM Syndrome Characteristics and Clinical Examples of 1200 Cases of COVID-19 in Chongqing [J]. Journal of Shaanxi University of Traditional Chinese Medicine, 2023, (02): 9-14. [doi: 10.13424/j.cnki.jsctcm.2023.02.002 ]
Copy

TCM Syndrome Characteristics and Clinical Examples of 1200 Cases of COVID-19 in Chongqing

References:

[1]Organization WH.Classification of omicron(B.1.1.529):SARS-CoV-2 variant of concern[EB/OL].(2021-12-31)[2022-12-18].https://www.who.int/news/item/26- 11- 2021-classificationof-Omicron-(B.1.1.529)-sars-cov-2-variant-of-concern.
[2]Christensen PA.Signals of significantly increased vaccine breakthrough,decreased hospitalization rates,and less severe disease in patients with coronavirus disease 2019 caused by the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Houston,texas[J].The American Journal of Pathology,2022,192(4):642-652.
[3]Menni C.Symptom prevalence,duration,and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of Omicron and delta variant dominance:a prospective observational study from the ZOE COVID Study[J].The Lancet,2022,399(10335):1618-1624.
[4]Xu XR.Analysis of mechanisms of Shenhuang Granule in treating severe COVID-19 based on network pharmacology and molecular docking[J].Journal of Integrative Medicine,2022,20(6):561-574.
[5]国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第九版)[EB/OL].(2022-03-15)\[2022-03-15].http://www.nhe.gov.cn/yzygj/s7653p/202203/b74adelba 4494583805a3d2e40093d88/6les/ef09aa4070244620b010 951b088b8a27.pdf.
[6]Kozlov M.Omicron's feeble attack on the Lungs could make it less dangerous[J].Nature,2022,601(7892):177.
[7]Brandal LT,MacDonald E,Veneti L,et al.Outbreak caused by the SARS-CoV-2 Omicron variant in Norway,November to December 2021[J].Eurosurveillance,2021,26(50):2101147.
[8]徐湘茹,孙鼎,曹敏,等.上海市4264例无症状及轻型新冠病毒感染者临床特征及预后转归分析[J].中华危重病急救医学,2022(5):449-453.
[9]方邦江,齐文升,黄烨.新型冠状病毒感染的肺炎中西医结合防控手册[M].北京:人民卫生出版社,2020:24-27.
[10]方邦江,齐文升,杨志旭,等.《新型冠状病毒肺炎诊疗方案(试行第九版)》中医治疗更新及其对奥密克戎变异株感染防治指导作用[J].陕西中医药大学学报,2022,45(3):1-4.
[11]Zhou S.Traditional Chinese medicine Shenhuang Granule in patients with severe/critical COVID-19:a randomized controlled multicenter trial[J].Phytomedicine,2021,89:153612.
[12]Wu XX,Zhou S,Liu CY,et al.Clinical predictive risk factors prolonged the duration of SARS-CoV-2 clearance in 279 moderate COVID-19 patients:a multicenter retrospective cohort study[J].Medicine,2021,100(40):e27410.
[13]方邦江,邬鑫鑫,张文,等.基于中医疫病理论之“表里双解”截断扭转法治疗新冠肺炎的理论与实践[J].陕西中医药大学学报,2022,45(4):1-7.
[14]方邦江,周爽.国医大师朱良春治疗疑难危急重症经验集[M].北京:中国中医药出版社,2013:80-88.
[15]方邦江,苏红,赵软金,等.新型冠状病毒奥密克戎变异株感染中医药防治专家共识[J].中国急救医学,2022,42(4):277-280.
[16]涂佳.浅谈温病特色诊法之舌诊[J].中国民间疗法,2021,29(10):22-24.
[17]周爽,卜建宏,孙丽华.方邦江治疗急重疑难病证学术经验[M].北京:中国中医药出版社,2018.
[18]戚亚婷,张玉峰,张依,等.急性胰腺炎中医治疗研究进展[J].中国中医药现代远程教育,2020,18(24):145-147.
[19]许禄华,黄小靖,李彦荣,等.基于 “温病在下其郁热” 探究大黄在新型冠状病毒肺炎的作用及潜在机制[J].中药药理与临床,2020,36(2):85-90.
[20]李雅莉,徐红日,曹鸿云,等.从免疫炎性损伤角度探讨5种清热解毒药物抗流感的机制及其临床意义[J].中国中医急症,2020,29(2):189-192,205.
[21]林思,秦慧真,邓玲玉,等.虎杖苷药理作用及机制研究进展[J].中国实验方剂学杂志,2021,27(22):241-250.

Memo

基金项目:国家重点研发计划项目(2018YFC1705900);国家中医药管理局 2022 年第五批新型冠状病毒感染肺炎中医药应急专项课题(2022ZYLCYJ05-4);上海中医药大学 2022 年度应对奥密克戎感染新型冠状病毒(2022YJ-03,2022YJ-06);重庆市教委科学技术研究计划项目(KJZD-K202215103);成都中医药大学2021年度“杏林学者”医院专项(YYZX2021065);成都中医药大学2021年度教育教学改革项目(JGJD2021024)

Last Update: 2023-03-27
Copyright @ 2020 Journal of Shaanxi University of Chinese Medicine
 Address: Middle Section of Century Avenue, Xianyang, Shaanxi Province. Post Code: 712046
Tel: 029-38185250 Fax: 029-38185250 E-mail: shxzhzs@163.com Powered by: www.editorhome.cn